Agreement signedAgreed 19 Nov 2022

Merck & /
Imago BioSciences, Inc.

Merck agrees to acquire Imago BioSciences for $36 per share

Price per share
$36/share
Stage
Agreement signed
Buy side: Merck &
Buy sideMerck &
Target: Imago BioSciences, Inc.
TargetImago BioSciences, Inc.
Source · 19 Nov 2022
Buy side: Merck &
Buy sideMerck &
Target: Imago BioSciences, Inc.
TargetImago BioSciences, Inc.
01 / BuyerMerck &
02 / TargetImago BioSciences, Inc.
01

What happened

Merck & Co., Inc. agreed to acquire Imago BioSciences, Inc. under an agreement dated Nov. 19, 2022. Its wholly owned subsidiary, M-Inspire Merger Sub, Inc., is offering $36.00 per share in cash.

The agreement provides for Imago BioSciences, Inc. to become a wholly owned subsidiary of Merck & Co., Inc. after the offer and merger.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Merck agrees to acquire Imago BioSciences for $36 per share

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.